Madison Regional Health System | |
323 Sw 10th St, Madison, South Dakota 57042 | |
(605) 256-8590 | |
Name | Madison Regional Health System |
---|---|
Location | 323 Sw 10th St, Madison, South Dakota |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
Medicare ID | 437054 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 57016, 57042, 57054, 57058, 57075, 57076, 57349 |
NPI Number | 1962472530 |
Organization Name | MADISON COMMUNITY HOSPITAL |
Doing Business As | D/B/A MADISON REGIONAL HEALTH SYSTEM |
Address | 323 Sw 10th St, Madison, SD 57042 |
Phone Number | 605-256-6551 |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
Quality Rating: |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 90.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 89.7 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | - | 96.4 |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 81.1 | 79.6 |
How often patients got better at getting in and out of bed | 93.3 | 81.1 |
How often patients got better at bathing | 88.3 | 82.3 |
How often patients’ breathing improved | 83.2 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 89.5 | 75 |
How often home health patients had to be admitted to the hospital | 19.1 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 10.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 98.3 | 94 |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
The patient survey data of Madison Regional Health System is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 77 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 75 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 59 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 66 | 78 |
News Archive
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company's Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older individuals, according to a Vanderbilt study that was published in the June 9 issue of the Journal of the American Medical Association.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of its SMARTer Ultra Low RNA Kit for Illumina Sequencing, which was developed in collaboration with Illumina, Inc.
BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.
› Verified 5 days ago
Madison Regional Health System Location: 323 Sw 10th St, Madison, South Dakota 57042 Ratings: Phone: (605) 256-8590 |